Please find the next edition of the Monthly Infectious Diseases Summary, our subjective look at the most important news of the month. Please let us know how you like it and if there is something interesting, we missed by contacting us at nac.contact@lgcgroup.com
Bangladesh Braces for Dengue Spike Amid Rainfall
Bangladesh is facing renewed dengue concerns as rains spark a rise in Aedes mosquito density. According to the Directorate General of Health Services (DGHS), 20 people have died and 2,586 have been hospitalised with dengue so far this year, with April seeing a notable spike. Experts warn that mosquito breeding indices are already higher than last year, raising fears of a severe surge by June if immediate control measures aren’t taken. Entomologists urge stronger government action, including establishing mosquito control units and eliminating breeding sites. Meanwhile, Dhaka’s city corporations have begun intensified mosquito control drives ahead of monsoon season. Read more >>
May 16th is National Dengue Day in India. The Native Antigen Company is a key player in the fight against these outbreaks, leading the development of virus-like particles (VLPs) for dengue and flaviviruses. As a trusted partner to major vaccine manufacturers and IVD companies, we support the production of rapid, effective serological screening tools, essential in addressing these emerging infectious diseases.
Avian Influenza A(H5N1) Case Confirmed in Mexico
On April 2, 2025, Mexico reported its first human infection with avian influenza A(H5N1) to the WHO. The case involved a child in Durango who developed symptoms in March and later died from respiratory complications. The infection's source remains under investigation, though recent bird outbreaks were confirmed in the area. No additional human cases have been linked to this incident so far. Read more >>
Czech Cities Implement Enhanced Public Transport Disinfection Amid Hepatitis A Increase
Several Czech cities, including Prague, are intensifying public transport disinfection efforts due to a Hepatitis A surge. Following COVID-19 protocols, buses, trams, and metros are undergoing more frequent cleaning to curb the virus's spread. This measure aims to protect public health as cases rise in urban centers. Hepatitis A symptoms include fever, fatigue, nausea, abdominal pain and jaundice, typically appearing 2–6 weeks after exposure. Read more >>.
At the Native Antigen Company we offer various antigens and antibodies against the Hepatitis Viruses, please let us know if there is any protein you cannot find in our portfolio, and we will manufacture it custom for you! Contact Us
Mumps Case Confirmed in Washtenaw County; Nationwide Cases Reported
Washtenaw County confirmed its first mumps case since 2018, with a second probable case reported on April 10, 2025. While symptoms are usually mild, adults are at greater risk for complications, including inflammation of the brain, reproductive organs, and even hearing loss. Across the U.S., 35 confirmed cases were reported in early 2025, particularly in close-contact settings like schools and colleges. Health officials urge residents to verify their MMR vaccination status and ensure they’ve received two doses for optimal protection. Maintaining high vaccination coverage is key to preventing further outbreaks. Read more >>
Rubella Virus Like Particles: The New Candidate of Choice for Diagnosing and Preventing Rubella
Rubella virus is notoriously difficult to culture and extremely challenging – and therefore costly – to propagate at scale. Replacing native rubella products on the market with recombinant VLPs may be the solution that researchers need.
Rubella IgM has become increasingly difficult to source natively at appropriate concentrations.
That's why LGC Clinical Diagnostics has developed a Rubella IgM recombinant that can be used as a replacement. Rubella IgM Recombinant (1200-0194, 1200-0195) offers Negative Rubella Plasma with Recombinant Rubella IgM at a concentration of -100ug/mL
Want to know more? Click below to download our product overview sheet.
